Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Dibetes in India: A Review


Affiliations
1 Shree Sureshdada Jain Institute of Pharmaceutical Education and Research Jamner Dist: Jalgaon. [M.S], India
2 Shree Sureshdada Jain Institute of Pharmaceutical Education and Research Jamner, Dist: Jalgaon. [M.S], India
     

   Subscribe/Renew Journal


Diabetes is a major cause of morbidity and mortality worldwide. Prevalence of diabetes is on rise in India and it may reflect changes in lifestyle. Major complications of diabetes are neuropathy, nephropathy, coronary artery disease and retinopathy. Improper diets, immigration effects, modification in life style, inter-population differences and obesity are the principal reasons for the augmentation of the diabetic prevalence. Diabetic prevalence in Chennai, Andhra and Kerala are 15.5%, 13.2% and 12.4% respectively. It has been estimated that India may have 80 million diabetic people in the year of 2030. Therefore, providing safe and effective measures are the need of the hour to control the explosion of the disease in India particularly its southern. The present review article gives a brief overview of diabetes, different factors leading to the increase in diabetic occurrence and complications particularly localizes in India.

Keywords

Diabetes, Type-1, Type-2, Insulin.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Shukla, R., Sharma, S.B., Puri, D., Murthy, P.S. Indigenous drugs for diabetes mellitus. JK. Sci. (2000). 2(3):128-130.

  • Chandra, A., Mahdhi, A.A., Ahmad, S., Singh, R.K. Indian herbs result in hypoglycemic responses in streptozotocin-induced diabetic rats. Nutr. Res. (2007). 27:161-168.

  • Grover, J.K., Yadav, S., Vats, V. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. (2002). 81:81-100.

  • Kuzuya, T., Nakagawa, S., Satoh, J., Kanazava, Y., Iwamoto, Y., Kobayashi, M., Nanjo, K., Sasaki, A., Seino, Y., Ito, C., Shima, K., Nonaka, K., Kadowaki, T. Report of the committee on the classification and diagnostic criteria of diabetes.

  • The Greatest Doctor of Ancient Times: Hippocrates and His Oath. Science & Children, March, 2010.

  • Medical Antiques, the practice of phisick Lithotomy. GP: General Practitioner, June, 2009.

  • P. Langerhans, Untersuchungen uber Petromyzon-Planery. Freiburg: C. Tromer, 1873.

  • P. Langerhans, Zur Aetiologie der Phythise. Archives of Pathological Anatomy, 1884, 97, 289-306.56-89.

  • Le Temps vecu. Etude phenomenologique et psychopathologique (1933, Delachaux), Ed.: PUF-Quadrige, 1995.

  • Vers une cosmologie, Fragments philosophiques, Aubier-Montaigne, Paris, 1936.

  • Traite de psychopathologie Intr. de Georges Lanteri Laura, Ed. Les empecheurs de penser en rond, 1966.

  • diabetes.niddk.nih.gov/dm/pubs/diagnosis/diagnosis.pdf.

  • http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf.

  • Tripathi, K.D., 2009, essentials of medical pharmacology, sixth edition, jaypee brothers medical publisher (p)LTD, new delhi, 254-255.

  • http://www.netdoctor.co.uk/diseases/facts/diabetes.htm.

  • Satyanarayana,u ., 2005, biochemisty, second edition, book and allied.(P)LTD kolkata 597-598.

  • http://www.betterhealth.vic.gov.au/bhcv2/bhcpdf.nsf/ByPDF/Diabetes_diagnostic_tests/$File/Diabetes_diagnostic_tests.pdf.

  • Kyvik, K.O., Nystrom, L., Gorus, F., Songini, M., Oestman, J., Castell, C., Green, A., Guyrus, G., Ionescu-Trigoviste, C., McKinney, P.A., Michalkova, D., Ostrauskas, R., Raymond, N.T. The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia. (2004). 47:377-384.

  • Karvonen, M., Viik-Kajander, M., Moltchanova, E., Libman, I., Laporte, R., Tuomilehto, J. Incidence of childhood type 1 diabetes world wide. Diabetes Care. (2000). 23:1516-1526.

  • Scheen, A.J. Pathophysiology of type 2 diabetes. Acta. Clin. Belg. (2003). 58(6):335-341.

  • Seshiah, V., Balaji, V., Balaji, M.S., Paneerselvam, A., Arthi, T., Thamizharasi, Manjula, D. Prevalence of gestational diabetes mellitus in South India (Tamil Nadu) - A community based study. J. Assoc. Physician. India. (2008). 56:329-333.

  • Thomas R Moore, MD et al. Diabetes Mellitus and Pregnancy. med/2349 at eMedicine. Version: Jan 27, 2005 update.

  • Donovan, PJ (2010). "Drugs for gestational diabetes". Australian Prescriber (33): 141-4.

  • Deb, A,C., 2004, fundamental of biochemistry, eighth edition, new central book agency (P) Ltd, kolkata, 270.

  • Craig, C.R., Stitzel, R..E., modern pharmacology with clinical application, sixth edition.

  • http://www.emedicinehealth.com/diabetes/article_em.htm.

  • http://www.netdoctor.co.uk/diseases/facts/diabetes.htm.

  • P.L. Starokadomskyy, I.Ya. Dubey, New absorption promoter for the buccal delivery: preparation and characterization of lysalbinic acid, Int. J. Pharm, 308, 2006, 149-154.

  • N.G.M. Schipper, J. Verhoef, S.G. Romeijn, Absorption enhancers in nasal insulin delivery and their influence on nasal cilliary functioning, J. Control. Release 21 1992, 173-186.

  • A. Bernkop-Schnurch, S, Synthesis and characterization of mucoadhesive thiolated, Int. J. Pharm, 194, 2000, 239-247.

  • Z.C. Shen, Y. Cheng, Q. Zhang, S.L. Wei, R.C. Li, K. Wang, Lanthanides enhance pulmonary absorption of insulin, Biol. Trace Elem. Res, 75, 2000, 215-225.

  • G.C. Chiou, B.H. Li, Chronic systemic delivery of insulin through the ocular route, J. Ocul. Pharmacol, 9, 1993, 85-90.

  • M.O. Yun, H.G. Choi, J.H. Jung, C.K. Kim, Development of a thermoreversible insulin liquid suppository with bioavailability enhancement, Int. J. Pharm. 189, 1999, 137-145.

  • http://exubra.com.


Abstract Views: 219

PDF Views: 2




  • Dibetes in India: A Review

Abstract Views: 219  |  PDF Views: 2

Authors

A. R. Umarkar
Shree Sureshdada Jain Institute of Pharmaceutical Education and Research Jamner Dist: Jalgaon. [M.S], India
A. K. Raut
Shree Sureshdada Jain Institute of Pharmaceutical Education and Research Jamner, Dist: Jalgaon. [M.S], India
S. S. Sonone
Shree Sureshdada Jain Institute of Pharmaceutical Education and Research Jamner, Dist: Jalgaon. [M.S], India
S. S. Pawar
Shree Sureshdada Jain Institute of Pharmaceutical Education and Research Jamner, Dist: Jalgaon. [M.S], India
R. S. Deshmukh
Shree Sureshdada Jain Institute of Pharmaceutical Education and Research Jamner, Dist: Jalgaon. [M.S], India
N. V. Bharude
Shree Sureshdada Jain Institute of Pharmaceutical Education and Research Jamner, Dist: Jalgaon. [M.S], India

Abstract


Diabetes is a major cause of morbidity and mortality worldwide. Prevalence of diabetes is on rise in India and it may reflect changes in lifestyle. Major complications of diabetes are neuropathy, nephropathy, coronary artery disease and retinopathy. Improper diets, immigration effects, modification in life style, inter-population differences and obesity are the principal reasons for the augmentation of the diabetic prevalence. Diabetic prevalence in Chennai, Andhra and Kerala are 15.5%, 13.2% and 12.4% respectively. It has been estimated that India may have 80 million diabetic people in the year of 2030. Therefore, providing safe and effective measures are the need of the hour to control the explosion of the disease in India particularly its southern. The present review article gives a brief overview of diabetes, different factors leading to the increase in diabetic occurrence and complications particularly localizes in India.

Keywords


Diabetes, Type-1, Type-2, Insulin.

References